A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol
Clinical trial NCT03274817 · TERMINATED
Trial details
- NCT number
- NCT03274817
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-18
- Primary completion
- 2019-09-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.